Literature DB >> 9234697

Regulation of IkappaB beta in WEHI 231 mature B cells.

R J Phillips1, S Ghosh.   

Abstract

Constitutive activation of NF-kappaB in WEHI 231 early mature B cells resembles the persistent activation of NF-kappaB that is observed upon prolonged stimulation of other cells. In both cases, NF-kappaB DNA binding complexes are found in the nucleus, despite the abundance of cytosolic IkappaB alpha. Recently, we have shown that prolonged activation of 70Z/3 cells with lipopolysaccharide results in the degradation of IkappaB beta, followed by its subsequent resynthesis as a hypophosphorylated protein. This protein was shown to facilitate transport of a portion of NF-kappaB to the nucleus in a manner that protects it from cytosolic IkappaB alpha. We now demonstrate that the most abundant form of IkappaB beta in WEHI 231 cells is a hypophosphorylated protein. This hypophosphorylated IkappaB beta is found in a stable complex with NF-kappaB in the cytosol and is also detected in NF-kappaB DNA binding complexes in the nucleus. It is likely that hypophosphorylated IkappaB beta in WEHI 231 cells also protects NF-kappaB from IkappaB alpha, thus leading to the continuous nuclear import of this transcription factor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234697      PMCID: PMC232293          DOI: 10.1128/MCB.17.8.4390

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.

Authors:  R P Ryseck; P Bull; M Takamiya; V Bours; U Siebenlist; P Dobrzanski; R Bravo
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

2.  Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65.

Authors:  R M Schmid; N D Perkins; C S Duckett; P C Andrews; G J Nabel
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

3.  Kappa B-specific DNA binding proteins are differentially inhibited by enhancer mutations and biological oxidation.

Authors:  J A Molitor; D W Ballard; W C Greene
Journal:  New Biol       Date:  1991-10

4.  B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.

Authors:  A Neri; C C Chang; L Lombardi; M Salina; P Corradini; A T Maiolo; R S Chaganti; R Dalla-Favera
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

5.  A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.

Authors:  V Bours; P R Burd; K Brown; J Villalobos; S Park; R P Ryseck; R Bravo; K Kelly; U Siebenlist
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

6.  Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B.

Authors:  T Henkel; T Machleidt; I Alkalay; M Krönke; Y Ben-Neriah; P A Baeuerle
Journal:  Nature       Date:  1993-09-09       Impact factor: 49.962

7.  Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity.

Authors:  S Haskill; A A Beg; S M Tompkins; J S Morris; A D Yurochko; A Sampson-Johannes; K Mondal; P Ralph; A S Baldwin
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

8.  The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation.

Authors:  R M Ten; C V Paya; N Israël; O Le Bail; M G Mattei; J L Virelizier; P Kourilsky; A Israël
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

9.  Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B.

Authors:  R de Martin; B Vanhove; Q Cheng; E Hofer; V Csizmadia; H Winkler; F H Bach
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

10.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.

Authors:  R Schreck; B Meier; D N Männel; W Dröge; P A Baeuerle
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

View more
  19 in total

1.  Cytoplasmic sequestration of rel proteins by IkappaBalpha requires CRM1-dependent nuclear export.

Authors:  W F Tam; L H Lee; L Davis; R Sen
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 2.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

Review 3.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

Review 4.  Role of transcription factors in inflammatory lung diseases.

Authors:  I Rahman; W MacNee
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

5.  Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells.

Authors:  S Miyamoto; B J Seufzer; S D Shumway
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

6.  Nuclear localization of IkappaB alpha is mediated by the second ankyrin repeat: the IkappaB alpha ankyrin repeats define a novel class of cis-acting nuclear import sequences.

Authors:  S Sachdev; A Hoffmann; M Hannink
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

7.  Calpain as an effector of the Gq signaling pathway for inhibition of Wnt/beta -catenin-regulated cell proliferation.

Authors:  Guangnan Li; Ravi Iyengar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-18       Impact factor: 11.205

8.  Persistent activation of RelA by respiratory syncytial virus involves protein kinase C, underphosphorylated IkappaBbeta, and sequestration of protein phosphatase 2A by the viral phosphoprotein.

Authors:  V Bitko; S Barik
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 9.  Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages.

Authors:  Amin Majdalawieh; Hyo-Sung Ro
Journal:  Mediators Inflamm       Date:  2010-04-12       Impact factor: 4.711

10.  IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response.

Authors:  Ping Rao; Mathew S Hayden; Meixiao Long; Martin L Scott; A Philip West; Dekai Zhang; Andrea Oeckinghaus; Candace Lynch; Alexander Hoffmann; David Baltimore; Sankar Ghosh
Journal:  Nature       Date:  2010-08-26       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.